SG/PUT/ILLUMINA/100/0.1/20.06.25 Stock

DE000SY2DK08

Market Closed - Boerse Frankfurt Warrants 03:43:45 2024-07-01 pm EDT
1.43 ^EUR	-3.38%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ILLUMINA, INC.

Latest news about ILLUMINA, INC.

RBC Lowers Price Target on Illumina to $242 From $249, Keeps Outperform Rating	Jul. 01	MT
ANALYST RECOMMENDATIONS : Nvidia, Broadcom, Progressive, Draftkings, Moody's...	Jul. 01
Would you like some more inflation?	Jun. 28
Illumina to Record $1.47 Goodwill Impairment Charge in Q2 After Grail Spin-Off	Jun. 28	MT

More news

Quotes 5-day view

Date	Price	Change
24-07-01	1.45	-2.03%
24-06-28	1.48	+2.78%

Real-time Boerse Frankfurt Warrants

Last update July 01, 2024 at 03:43 pm EDT

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	PUT
Underlying	ILLUMINA, INC.
Issuer	Société Générale
WKN	SY2DK0
ISIN	DE000SY2DK08
Date issued	2024-06-27
Strike	100 $
Maturity	2025-06-20 (354 Days)
Parity	10 : 1
Emission price	1.47 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.48 €
Lowest since issue	1.36 €
Spread	0.01 €
Spread %	0.70%

Company Profile

Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (84.1%): tools and instruments for sequencing, genotyping, genetic expression, etc.; - sales of services (15.9%). Net sales are distributed geographically as follows: the United States (52.4%), Americas (3.6%), Europe (25.3%), Asia/Pacific/Middle East/Africa (10.2%) and China/Taiwan/Hong Kong (8.5%).

Sector

More about the company